Cytochemistry of the hormonal receptors in hormone-responsive tumors. the role of the pathologist
Nenci, I.
Pathologica 71(1014): 431-441
1979
ISSN/ISBN: 0031-2983 PMID: 232910 Document Number: 144763
Document emailed within 1 workday
Related Documents
Takizawa, S.; Furth, J.J.; Furth, J. 1970: DNA synthesis in autonomous and hormone-responsive mammary tumors Cancer Research 30(1): 206-210Smith, J.A.; King, R.J. 1970: Biochemical studies on hormone-responsive mammary tumors in BR6 mice Cancer Research 30(7): 2055-2060
Moncharmont, B.; Ramp, G.; De Goeij, C.C.; Sluyser, M. 1991: Comparison of estrogen receptors in hormone-dependent and hormone-independent Grunder strain mouse mammary tumors Cancer Research 51(15): 3843-3848
Bouzourene, H. 2009: The role of the pathologist in the management of gastrointestinal stromal tumors (GIST) Revue Medicale Suisse 5(211): 1505-1508
Giard, R.W. 1995: The changed role of the pathologist in medical care. II. what should and what should not go to the pathologist? Nederlands Tijdschrift Voor Geneeskunde 139(3): 110-113
Comandone, A.; Sciascia, C.; Enrichens, F.; Olivero, G.; Foco, A.; Fiori, M.G.; Sanfelici, G.; Gallingani, R. 1988: Colorectal tumors and hormonal receptors. A critical review of the literature Minerva Medica 79(6): 455-461
Contieri, E.; Liguori, G.; De Rosa, G.; Di Prisco, D.; Bevilacqua, A.M.; Tatangelo, F.; Masucci, M.T.; Sica, V. 1986: Correlation between hormonal receptors and grading in tumors of the digestive system Minerva Chirurgica 41(5-6): 431-433
Rybin, E.P.; Tsyrlina, E.V.; Gamaiunova, V.B.; Vishnevskiĭ, A.S.; Livshits, M.A.; Semiglazov, V.F.; Bershteĭn, L.M.; Bokhman, I.V. 1996: Specifics of reproductive disorders and hormonal sensitivity of tumors in patients with "hormone-related neoplastic syndrome" Voprosy Onkologii 42(3): 45-50
Leveque, J.; Foucher, F.; Havouis, R.; Desury, D.; Grall, J.Y.; Moulinoux, J.P. 2000: Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo Anticancer Research 20(1a): 97-101
Hsieh, T-Chen.; Lu, X.; Guo, J.; Xiong, W.; Kunicki, J.; Darzynkiewicz, Z.; Wu, J.M. 2002: Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies International Journal of Oncology 20(4): 681-689
Sharpe R.M. 1979: Modulation of prolactin luteinizing hormone and follicle stimulating hormone secretion by luteinizing hormone releasing hormone and bromocriptine cb 154 in the hypophysectomized pituitary grafted male rat and its effect on testicular luteinizing hormone receptors and testosterone output Biology of Reproduction 21(1): 141-148
Medina, D.; Iramain, C.A.; Clark, J.H. 1975: Hormone dependence and estradiol receptors in the D series of mammary nodule outgrowth lines and tumors Cancer Research 35(9): 2355-2369
Shain, S.A.; Boesel, R.W.; Kalter, S.S.; Heberling, R.L. 1981: A x C rat prostate adenocarcinoma: initial characterization of testosterone regulation of hormone receptors of cultured cancer cells and derived tumors Journal of the National Cancer Institute 66(3): 565-574
Rogozkin, V.A. 1987: The role of phosphorylation and dephosphorylation of receptors in the regulation of steroid hormone binding Ukrainskii Biokhimicheskii Zhurnal 59(5): 100-112
McGuire, W.L. 1978: Hormone receptors: their role in predicting prognosis and response to endocrine therapy Seminars in Oncology 5(4): 428-433
Balaton, A.L.; Coindre, J.M.; Collin, F.; Ettore, F.; Fiche, M.; Jacquemier, J.; Le Doussal, V.; Mandard, A.M.; Mathieu, M.C.; Migeon, C.; Simony-Lafontaine, J.; Treilleux, I.; Verriele, V.; Vilain, M.O.; Zafrani, B. 1996: Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology Annales de Pathologie 16(2): 144-148
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Giovannini, M.; Pasquier, J.; Brenot-Rossi, I.; Perrier, H.; Sauvan, R.; Seitz, J.F. 1995: The role of echoendoscopy and scintigraphy of somatostatin receptors in the staging of neuro-endocrine digestive tumors Annales de Gastroenterologie et d'Hepatologie 31(2): 109-113
Vieillefond, A.; Quillard, J.; Ladouch-Badré, A.; Meduri, G.; Nenert, M.; Matani, A.; Martin, E. 1989: Tumors of the bladder. the pathologist's point of view Annales de Pathologie 9(4): 249-264
Christophe, J.; Waelbroeck, M.; Robberecht, P. 1982: Hormone and neuroeffector receptors in gastroenterology. a concrete example: the VIP (vasoactive intestinal peptide) receptors Acta Gastro-Enterologica Belgica 45(7-8): 280-291